A股異動 | 德方納米漲停 擬在曲靖建磷酸鐵鋰生產項目
格隆匯3月11日丨德方納米(300769.SZ)漲停,報179.73元,暫成交1.78億元,最新總市值76.8億。公司昨日公告稱,3月6日與曲靖經濟技術開發區管理委員會簽署了《投資協議書》,公司擬在曲靖經濟技術開發區管理委員會轄區內投資建設“磷酸鐵鋰生產項目”,計劃總投資額約10億元。此次對外投資主要是為了進一步擴大公司磷酸鐵鋰產能,更好地滿足鋰離子正極材料中高端市場對公司產品的需求,有利於公司做大、做強、做精主業,從而進一步增強公司的整體實力,也將進一步鞏固並提高公司的行業地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.